news roundup
Rho is providing operational management and oversight for all aspects of the study, which is being conducted with Division of Allergy, Immunology, and Transplantation Statistical and Clinical Coordinating Center Vanderbilt and other investigators. The virtual trial is enrolling children and their families for six months to determine who gets infected with SARS-CoV-2, whether the virus is transmitted to other family members and which family members with the virus develop COVID-19 as a result.
iSpecimen and Onsite HealthCare have partnered to provide mobile phlebotomists to visit the residence of patients who have recovered from a COVID-19 infection and draw blood or collect other samples that will be delivered to research teams for use in their studies.
ERT’s Virtual Visit solution enables at-home consultations between patients and investigative site personnel via a dedicated, secure app or web interface.
Take a moment to nominate someone, or read the wonderful entries submitted and then vote for Florence Healthcare’s The Florence Effect in Clinical Research. Anyone who works in a role related to clinical research is eligible – from research sites to sponsors, CROs, and other organizations. For each nomination, The Florence Effect will make a donation to Greater Gift and the winner will receive a $500 American Express gift card.
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
|
|
|
|
|
|
|
|
advertisement
Bioforum, the Forum for EmergingBio's Outsourcing Decisions
As the biopharma industry traverses unchartered waters amid the COVID-19 crisis and doubles down on its efforts to bring new therapies to market faster, cheaper and without affecting quality, the success of strategic partnerships and functional service provider models will become more critical than ever before.
Read the article
|
|
Articles |
|
In this Q&A, Gen Li, PhD, CEO and founder of Phesi, a clinical development analytical products and services provider, outlines the current COVID-19 landscape for research sites. He suggests sponsors need to keep funding sites–even those that are suspended and keep them operational–to avoid the worst of the current implications and mitigate the long-term impact of COVID-19.
|
|
On the eve of International Clinical Trials Day on May 20, a panel of European experts reflected on the impact so far of the COVID-19 outbreak on clinical trials—and, crucially, on what impact it may have on the future of clinical trials everywhere.
|
Blog Posts
The Institute for Quality and Efficiency in Health Care (IQWiG ) is pushing for the earliest feasible release of clinical study reports (CSR) for authorized treatments and vaccines for COVID-19 on the day of marketing authorization in a bid to open up research in the field.
|
|
|
|
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
|
